Benfotiamine is a fat-soluble prodrug of vitamin B1 and is rapidly converted into vitamin B1 after administration. It is used as a medication for the treatment of diabetic neuropathy but is also used as a dietary supplement.
Comprehensive documentation for drug registration of Benfotiamine can be provided by Biesterfeld as referred.
|CAS-No. || Regulatory || Monograph |
|22457-89-2 || ASMF || IH|